I am the director of the Nanomedicine Research Center for drug delivery and nanomedicine in the Department of Neurosurgery at Cedars-Sinai. My main interests are in differential cancer genomic and proteomic signatures as a tool for finding novel, early markers of cancer growth, and in development and design of new nanomedicine drugs against these and other tumor targets."
The Ljubimova Laboratory is working to create a new generation of nanomedicine imaging agents and nanodrugs to bring them to clinical practice. The nanodrugs are biodegradable and nontoxic for patients and deliver multiple antitumor inhibitors, at the same time, directly to cancer cells, overcoming drug resistance and improving treatment efficacy and the quality of cancer patients' lives.
- Claus-Michael Lehr, PhD
Professor, Head, Department of Drug Delivery (DDEL) of the
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
- Manuel Penichet, MD, PhD
Microbiology, Immunology and Molecular Genetics
Member, Clinical and Translational Science Institute
California NanoSystems Institute
Jonsson Comprehensive Cancer Center Tumor Immunology Program Area
Faculty, Molecular Biology Interdepartmental PhD
- Paula T. Hammond, PhD
Bayer Professor and Executive Officer
Department of Chemical Engineering
Koch Institute for Integrative Cancer Research
Associate Editor, ACS Nano
Massachusetts Institute of Technology, Cambridge, Mass.
- Meng Ellis, PhD
Professor of Biomedical Engineering
Chair of the Women in Science and Engineering Program
Viterbi School of Engineering
University of Southern California, Los Angeles
- Carlos Lodero, PhD, and Jose Capello, PhD
Nova University of Lisbon
Department of Chemistry
Faculty of Science and Technology
- Alexander Lyubimov, MD, PhD
University of Illinois
Department of Toxicology
Diplomate of the American Board of Toxicology Director
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Ljubimova Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Ding H, Gangalum PR, Galstyan A, Fox I, Patil R, Hubbard P, Murali R, Ljubimova JY, Holler E.
2017, Nanomedicine. 2017 Feb;13(2):631-639.
Anchordoquy TJ, Barenholz Y, Boraschi D, Chorny M, Decuzzi P, Dobrovolskaia MA, Farhangrazi ZS, Farrell D, Gabizon A, Ghandehari H, Godin B, La-Beck NM, Ljubimova J, et al.
ACS Nano. 2017 Jan 24;11(1):12-18.
Ding H, Fox I, Patil R, Galstyan A, Black KL, Ljubimova JY, Holler E.
J Nanomater. 2017;2017. pii: 4238697.